|
Characteristics
|
Number of patients
|
%
|
|---|
|
Age, median y (range)
|
43 (17–80)
| |
|
Sex
| | |
|
Male
|
113
|
69.3
|
|
Female
|
50
|
30.7
|
|
ECOG score
| | |
|
0-1
|
151
|
92.6
|
|
≥ 2
|
12
|
7.4
|
|
Serum LDH > 245 u/l
|
55
|
33.7
|
|
B symptoms
|
85
|
52.1
|
|
Extranodal sites of involvement ≥ 2
|
23
|
14.1
|
|
Ann Arbor Stage
| | |
|
I-II
|
128
|
78.5
|
|
III-IV
|
35
|
21.5
|
|
Subtype
| | |
|
UNKTL
|
140
|
85.9
|
|
EUNKTL
|
23
|
14.1
|
|
Regional lymph node involvementa
|
53
|
38.4
|
|
KPI scoreb
| | |
|
0-1
|
84
|
60.9
|
|
2-4
|
54
|
39.1
|
|
IPI score
| | |
|
0-1
|
125
|
76.7
|
|
2-5
|
38
|
23.3
|
|
AMC ≥ 0.50×109/L
|
118
|
72.4
|
- Abbreviations: ECOG PS, Eastern Cooperative Oncology Group performance status; LDH, lactate dehydrogenase; UNKTL, upper aerodigestive tract NK/T-cell lymphoma; EUNKTL, extraupper aerodigestive tract NK/T-cell lymphoma; KPI, Korean Prognostic Index; IPI, International Prognostic Index; AMC, absolute monocyte count.
-
a Complete data on regional lymph node involvement was available in 138 patients.
-
b Complete data on KPI prognostic score was assessable in 138 patients.
